Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8792LA | OT |
pregnant patient recived FLUZONE with no reported adverse event; Initial information received on 08-Sep-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 33 years old female pregnant patient who was received influenza USP TRIVAL A-B subvirion no preservative vaccine [Fluzone] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported event occurred at unknown gestation period. The date of last menstrual period was reported as 24-Jul-2025. The estimated due date is 01-May-2026. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown number of previous pregnancy/ies. On an unknown date in 2025, the patient received an unknown dose 1 of influenza USP TRIVAL A-B subvirion no preservative vaccine Suspension for injection (strength- unknown, expiry date- 30-JUN-2026 and lot UT8792LA) via intramuscular route in unknown administration site for Prophylactic vaccination (Immunisation) with no reported adverse event (exposure during pregnancy) (same day latency). Reportedly, the patient did not receive any treatment for infertility. The patient did not experience any adverse events. There were no relevant prenatal testing after exposure. Action taken was not applicable. Additionally, at time of reporting, the pregnancy is still ongoing.